re: Ann: Ivanhoe clarifies position on Exco... Looks like Ivanhoe is going to lean on Exco to maximise the return form the sale.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025